Additionally, they identified three upregulated metabolites that could serve as biomarkers for obesity: (1) androsterone, a steroid hormone that may increase adipose tissue deposition (O’Reilly et al., 2014), (2) heparan sulfate proteoglycan (HSPG) degradation products, where HSPGs regulate the transport of lipoprotein lipase across endothelial cells to adipocytes (Saxena et al., 1991), and (3) ganglioside GM2, a molecule associated with insulin signaling in adipocytes (Tanabe et al., 2009). This evidence concerns the gene INS and obesity disorder.